Member Info for PJT12

Did Columbus need charts to discover America? Precisely! My case rests.....................

Richob, therein lies another part of the problem. Posters who take a thread and twist it to suit there needs. The supposed NDA was another example. The bottom line? WE DON'T KNOW.

Time Trade Price Volume Value
09:16:10 232.00 30,000 69.60k O
09:15:55 231.00 30,000 69.30k O

"Soon" :)

16:36:28 236.70313 160,000 378.73k O

I think it would be a good idea to start an Avacta Archive to ensure that the historic building of the LFT is recorded for posterity. Quotes from Dr Alastair Smith seem a good way to chart the course we've taken to date and so here's a couple with that in mind.........

24 Nov 2020 Alastair Smith, Chief Executive Officer of Avacta Group, commented:

"I am delighted with the excellent progress that has been made with BBI Solutions in developing a scalable version of a lateral flow rapid SARS-CoV-2 antigen test with sensitivity in the expected clinical range for spike protein.

24 June 2020 Alastair Smith, Chief Executive Officer of Avacta Group, commented:

"I am delighted with the progress made by our partners at Cytiva and very encouraged by the positive data from the first test devices. We now need to optimise the test performance to achieve the best possible limit of detection as this will ultimately play a significant factor in determining the clinical sensitivity of the test.
This is a really positive step and we aim to have completed the optimisation very soon so that we can begin the transfer to manufacturers. I will be updating the market on progress in due course."

AVACTA CEO 24 June 2020

"I am delighted with the progress made by our partners at Cytiva and very encouraged by the positive data from the first test devices. We now need to optimise the test performance to achieve the best possible limit of detection as this will ultimately play a significant factor in determining the clinical sensitivity of the test.
This is a really positive step and we aim to have completed the optimisation very soon so that we can begin the transfer to manufacturers. I will be updating the market on progress in due course."

PL75, thank you for the civil responses.

jdt1990, perhaps you could ask AS to spend some of that dosh on his stressed-out investors such as yourself? Anger management classes perhaps? Although, judging by his track record, it might be quicker for you to jump onto one of those NHS waiting lists. Anyway, can't sit around all day waiting for your next 'potty-mouth' to activate itself again. Happy waiting.

Ah, yes, there it is. Consider me reassured.

jdt1990, thank you for clarifying although your language suggests that your comfort level is not exactly bolstered by said amount. Please can you give me the date of the RNS in which that figure was stated as it would provide me with some much needed reassurance after last years "unexpected" rights issue . As I understood it from last year's fund raising:

Rapid Scale-up of Diagnostics Business, £10 million (incl. Wetherby Affimer production facilities (Not cheap):

· Working capital for the COVID-19 testing opportunity

· Expansion of in-house diagnostics product development capabilities including facilities, capital equipment; scientific, commercial and senior leadership teams

· Acceleration of broader diagnostics product pipeline and commercial partnerships

My main concern is how much of the Covid 19 designated money raised from last year's "unexpected" rights issue remains? That, along with AS and David Wilson's lack of any LFT product to market after all this time - and contrary to all the misplaced timelines - is concerning. Cytiva now feels like a distant memory, although I note that Sona is still giving it a go:

Halifax, Nova Scotia--(Newsfile Corp. - April 12, 2021) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company" or "Sona"), a developer of rapid, point-of-care diagnostic tests is pleased to announce that it has been granted Health Canada Investigational Testing Authorization for a clinical trial of the Sona Saliva C-19 Rapid Test, a saliva sample-based rapid COVID-19 antigen test, with the Humber River Hospital in Toronto. The trial is expected to commence shortly, following final ethics review board sign-off of the trial protocol amendments required by Health Canada. The trial's objective is to determine the clinical performance of the test when compared to RT-PCR, in symptomatic patients. Analytical validation studies would also be required to support any regulatory submissions

"They have to RNS the upcoming investor presentation regardless of other news in the pipeline. For all we know we could have the s/s results by this time tomorrow." Spot on - or even within the hour.

Timster, don't you mean he's a concerned "investor"? :-)

But, imo, this is the most ominous:

https://www.indiatoday.in/coronavirus-outbreak/story/20-maha-cases-new-double-mutant-variant-experts-to-find-impact-on-vaccines-1789754-2021-04-11

The link is indiatoday

Sangijuelas1, if you ain't got nothing nice to say................

I still wouldn't go into a packed football stadium, passports or otherwise, unless Social Distancing measures were in place. "Credible means of allowing full capacity venues"? They would say that, wouldn't they?

Davand, you avoiding my question?

Only? 8.8p? Sounds good to me. We are perfectly capable of making our own investment decisions so where does your agenda lie? C'mon, what's the thinking behind your negativity? What are you hoping to achieve - other than knocking the price down?

Davand, your first of 3 posts was today and all of them have been negative. That suggests to me that you are not a holder and are more likely a deramper. For the record, I bought in today.

What happens to your shares when the company has been suspended?
In such circumstances, you remain a shareholder with all of the rights of a shareholder under company law, but you will be unable to execute or place any trades for the securities of the company in question.

Nevertheless, the suspended company must still comply with all listing rules applicable to it. This means that shareholders should continue to receive announcements on developments that require announcement under these rules, so you shouldn’t be left completely in the dark. In addition, once the circumstances leading to the suspension have been resolved or clarified sufficiently, then a notification to the market is immediately required.

Finally, when it comes to AIM, should the securities of any company be suspended for six months, the securities will be be cancelled from trading unless an extension has been granted.